106 related articles for article (PubMed ID: 20629201)
1. Differential effects of ketoconazole and primaquine on the pharmacokinetics and tissue distribution of imatinib in mice.
Soo GW; Law JH; Kan E; Tan SY; Lim WY; Chay G; Bukhari NI; Segarra I
Anticancer Drugs; 2010 Aug; 21(7):695-703. PubMed ID: 20629201
[TBL] [Abstract][Full Text] [Related]
2. Metronidazole leads to enhanced uptake of imatinib in brain, liver and kidney without affecting its plasma pharmacokinetics in mice.
Tan SY; Kan E; Lim WY; Chay G; Law JH; Soo GW; Bukhari NI; Segarra I
J Pharm Pharmacol; 2011 Jul; 63(7):918-25. PubMed ID: 21635257
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic interaction between ketoconazole and imatinib mesylate (Glivec) in healthy subjects.
Dutreix C; Peng B; Mehring G; Hayes M; Capdeville R; Pokorny R; Seiberling M
Cancer Chemother Pharmacol; 2004 Oct; 54(4):290-4. PubMed ID: 15138710
[TBL] [Abstract][Full Text] [Related]
4. HPLC determination of imatinib in plasma and tissues after multiple oral dose administration to mice.
Teoh M; Narayanan P; Moo KS; Radhakrisman S; Pillappan R; Bukhari NI; Segarra I
Pak J Pharm Sci; 2010 Jan; 23(1):35-41. PubMed ID: 20067864
[TBL] [Abstract][Full Text] [Related]
5. Effect of St John's wort on imatinib mesylate pharmacokinetics.
Frye RF; Fitzgerald SM; Lagattuta TF; Hruska MW; Egorin MJ
Clin Pharmacol Ther; 2004 Oct; 76(4):323-9. PubMed ID: 15470331
[TBL] [Abstract][Full Text] [Related]
6. Disposition and tissue distribution of imatinib in a liposome formulation after intravenous bolus dose to mice.
Moo KS; Radhakrishnan S; Teoh M; Narayanan P; Bukhari NI; Segarra I
Yao Xue Xue Bao; 2010 Jul; 45(7):901-8. PubMed ID: 20931790
[TBL] [Abstract][Full Text] [Related]
7. Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients.
Gambacorti-Passerini C; Zucchetti M; Russo D; Frapolli R; Verga M; Bungaro S; Tornaghi L; Rossi F; Pioltelli P; Pogliani E; Alberti D; Corneo G; D'Incalci M
Clin Cancer Res; 2003 Feb; 9(2):625-32. PubMed ID: 12576428
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: a randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers.
Parrillo-Campiglia S; Ercoli MC; Umpierrez O; Rodríguez P; Márquez S; Guarneri C; Estevez-Parrillo FT; Laurenz M; Estevez-Carrizo FE
Clin Ther; 2009 Oct; 31(10):2224-32. PubMed ID: 19922893
[TBL] [Abstract][Full Text] [Related]
9. Sunitinib tissue distribution changes after coadministration with ketoconazole in mice.
Chee EL; Lim AY; Modamio P; Fernandez-Lastra C; Segarra I
Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):309-19. PubMed ID: 25656737
[TBL] [Abstract][Full Text] [Related]
10. Effect of azole antifungals ketoconazole and fluconazole on the pharmacokinetics of dexloxiglumide.
Jakate AS; Roy P; Patel A; Abramowitz W; Persiani S; Wangsa J; Kapil R
Br J Clin Pharmacol; 2005 Nov; 60(5):498-507. PubMed ID: 16236040
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic-pharmacodynamic relationships of imatinib and its main metabolite in patients with advanced gastrointestinal stromal tumors.
Delbaldo C; Chatelut E; Ré M; Deroussent A; Séronie-Vivien S; Jambu A; Berthaud P; Le Cesne A; Blay JY; Vassal G
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6073-8. PubMed ID: 17062683
[TBL] [Abstract][Full Text] [Related]
12. Influence of hydroxyurea on imatinib mesylate (gleevec) transport at the mouse blood-brain barrier.
Bihorel S; Camenisch G; Gross G; Lemaire M; Scherrmann JM
Drug Metab Dispos; 2006 Dec; 34(12):1945-9. PubMed ID: 16936068
[TBL] [Abstract][Full Text] [Related]
13. Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects.
Bolton AE; Peng B; Hubert M; Krebs-Brown A; Capdeville R; Keller U; Seiberling M
Cancer Chemother Pharmacol; 2004 Feb; 53(2):102-6. PubMed ID: 14605865
[TBL] [Abstract][Full Text] [Related]
14. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
[TBL] [Abstract][Full Text] [Related]
15. Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotype.
Gurney H; Wong M; Balleine RL; Rivory LP; McLachlan AJ; Hoskins JM; Wilcken N; Clarke CL; Mann GJ; Collins M; Delforce SE; Lynch K; Schran H
Clin Pharmacol Ther; 2007 Jul; 82(1):33-40. PubMed ID: 17495881
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetic-pharmacodynamics relationships of imatinib (Glivec)].
Delbaldo C
Therapie; 2007; 62(2):87-90. PubMed ID: 17582306
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.
Wen PY; Yung WK; Lamborn KR; Dahia PL; Wang Y; Peng B; Abrey LE; Raizer J; Cloughesy TF; Fink K; Gilbert M; Chang S; Junck L; Schiff D; Lieberman F; Fine HA; Mehta M; Robins HI; DeAngelis LM; Groves MD; Puduvalli VK; Levin V; Conrad C; Maher EA; Aldape K; Hayes M; Letvak L; Egorin MJ; Capdeville R; Kaplan R; Murgo AJ; Stiles C; Prados MD
Clin Cancer Res; 2006 Aug; 12(16):4899-907. PubMed ID: 16914578
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of ketoconazole, itraconazole and voriconazole on the pharmacokinetics of imatinib and its main metabolite GCP74588 in rat.
Lin G; Wang C; Qiu X; Wang Z; Han A; Xu T; Kan X; Hu G
Drug Dev Ind Pharm; 2014 Dec; 40(12):1616-22. PubMed ID: 24053419
[TBL] [Abstract][Full Text] [Related]
19. Effect of cigarette smoking on imatinib in patients in the soft tissue and bone sarcoma group of the EORTC.
van Erp N; Gelderblom H; van Glabbeke M; Van Oosterom A; Verweij J; Guchelaar HJ; Debiec-Rychter M; Peng B; Blay JY; Judson I
Clin Cancer Res; 2008 Dec; 14(24):8308-13. PubMed ID: 19088049
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.
Menon-Andersen D; Mondick JT; Jayaraman B; Thompson PA; Blaney SM; Bernstein M; Bond M; Champagne M; Fossler MJ; Barrett JS
Cancer Chemother Pharmacol; 2009 Jan; 63(2):229-38. PubMed ID: 18398615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]